Agilus Launches 3-Hour Cancer Mutation Test in Mumbai

Precision oncology in India has received a major boost with a new automated testing platform in Mumbai. Specifically, Agilus Diagnostics launched the Idylla molecular diagnostics system to enable rapid cancer mutation testing at its Goregaon facility. As a result, clinicians can now detect clinically relevant genetic mutations within just 2.5 to 3 hours. In comparison, traditional testing methods often take several days to deliver results. Therefore, oncologists can make time-sensitive treatment decisions much faster than before.

The Power of Rapid Cancer Mutation Testing

The Idylla platform is a fully integrated, cartridge-based system. Moreover, it combines sample processing, nucleic acid extraction, amplification, and detection into a single automated workflow. Consequently, the system minimizes manual intervention and reduces pre-analytical errors. This automation ensures highly accurate and reproducible results for patients. Additionally, the platform performs exceptionally well even when tissue samples are extremely limited. For this reason, pathologists can deliver critical genomic insights without delay.

Key Biomarkers Detected by the System

The system rapidly detects several critical genetic mutations. Importantly, these include EGFR mutations, which are highly prevalent in Indian lung cancer patients. Furthermore, it identifies KRAS and NRAS mutations, which are crucial biomarkers in colorectal and pancreatic cancers. Similarly, the system tests for BRAF mutations, which occur in melanoma and colorectal cancers. Besides these established markers, the platform also analyzes emerging biomarkers like Microsatellite Instability (MSI) and IDH1/IDH2 mutations. Indeed, these markers are vital for determining patient eligibility for advanced targeted therapies and immunotherapies.

Improving Patient Outcomes in India

Faster molecular profiling directly translates to earlier initiation of appropriate therapies. For instance, delaying biomarker identification can significantly postpone crucial cancer treatment. Conversely, quick access to genomic data helps clinicians match patients with targeted treatments immediately. Ultimately, this advanced diagnostics ecosystem strengthens precision medicine in India.

Frequently Asked Questions

Q1: What is the turnaround time for the new cancer mutation test?

Specifically, the Idylla molecular diagnostics system provides highly accurate results within 2.5 to 3 hours. In comparison, traditional methods can take several days.

Q2: Which cancer biomarkers does this rapid testing system detect?

Specifically, the platform detects key mutations including EGFR, KRAS, NRAS, and BRAF. Additionally, it identifies emerging markers like Microsatellite Instability (MSI) and IDH1/IDH2.

References

1. Rapid cancer mutation testing in 3 hours could accelerate precision treatmentdecisions – ETHealthworld
2. Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours – Indian Pharma Post
3. Agilus Diagnostics launches Idylla System for rapid detection of cancer mutations – Biospectrum India

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.